世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

膿痂疹治療薬の世界市場インサイト、2029年までの予測


Global Impetigo Medicines Market Insights, Forecast to 2029

世界の膿痂疹治療薬市場は、COVID-19とロシア・ウクライナ戦争の二重の影響を受けた2022年の100万米ドルに比べ、2023年には100万米ドルに達すると予想されている。川下産業からの需要増加を背景に、膿痂疹治療薬... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2023年10月6日 US$4,900
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

世界の膿痂疹治療薬市場は、COVID-19とロシア・ウクライナ戦争の二重の影響を受けた2022年の100万米ドルに比べ、2023年には100万米ドルに達すると予想されている。川下産業からの需要増加を背景に、膿痂疹治療薬産業は2029年に百万米ドルに達すると評価されている。2023年から2029年までのCAGRは%である。

世界の医薬品市場は、2022年に1475億米ドルとなり、今後6年間のCAGRは5%で成長する。医薬品市場には、化学医薬品と生物学的製剤が含まれる。生物製剤は2022年に3810億ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間&政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要とする患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の流行はワクチン開発とサプライチェーン・マネジメントの重要性を浮き彫りにし、製薬企業が新たな公衆衛生のニーズに機敏に対応する必要性をさらに強調している。

レポートの対象
本レポートは、2018年から2029年までの世界の膿痂疹治療薬市場の概要を紹介し、読者が世界の膿痂疹治療薬市場を多角的に包括的に理解することを目的としています。2018年から2029年までの地域別の売上高、収益、2018年から2023年までのメーカーの売上高、価格、収益、粗利益率などの項目を分析しています。さらに、2018年から2029年までの各地域における製品タイプおよび用途の売上高と収益も強調しています。

レポートに掲載されているメーカー、タイプ、アプリケーション、地域
企業別
Cutanea Life Sciences
レオファーマ
メディメトリックス・ファーマシューティカルズ
グラクソ・スミスクライン
ファイザー
カラレックス・ファーマ
ノバベイ・ファーマシューティカルズ
ロシュ・ホールディングAG
サンドスGmbH
タロ・ファーマシューティカル・インダストリーズ
テバ・ファーマシューティカル・インダストリーズ
タイプ別セグメント
漢方薬
西洋薬
用途別セグメント
病院
薬局
地域別セグメント
米国・カナダ
米国
カナダ
中国
アジア(中国を除く)
日本
韓国
中国 台湾
東南アジア
インド
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
ラテンアメリカ、中東、アフリカ
ブラジル
メキシコ
トルコ
イスラエル
GCC諸国

章の概要
第1章:製品の定義、種類、用途の紹介
第2章:2018年から2029年までの地域別収益および販売量分析
第3章:メーカーの膿痂疹治療薬の工場分布、膿痂疹治療薬の市販日、提供される製品タイプ、M&A、拡大活動を含むメーカーの売上、収益、価格分析
第4章:2018年から2029年までの世界のタイプ別製品売上高、収益、価格分析
第5章:2018年から2029年までの世界的な用途別製品売上高、収益および価格分析
第6章:米国・カナダにおける2018年から2029年までのタイプ別・用途別製品売上高、収益分析2018年から2029年までの米国&カナダにおける各国別製品売上高、収益分析
第7章:ヨーロッパにおける2018年から2029年までの製品の販売、タイプ別および用途別収益分析。2018年から2029年までの欧州各国の製品売上高、収益分析
第8章:2018年から2029年までの中国における製品の売上高、タイプ別および用途別の収益分析。2018年から2029年までの中国の製品売上高、収益分析
第9章:2018年から2029年までのアジア(中国を除く)における製品売上高、タイプ別および用途別収益分析。2018年から2029年までのアジア(中国を除く)各国の製品売上高、収益分析
第10章:2018年から2029年までの中東、アフリカ、ラテンアメリカにおける製品の販売、タイプ別および用途別収益分析。2018年から2029年までの中東、アフリカ、ラテンアメリカの各国における製品売上高、収益分析。
第11章:メーカーの概要、企業の基本情報、主要事業、膿痂疹治療薬の紹介など。2018年から2023年までの各社の膿痂疹治療薬の売上高、収益、価格、およびグロスマージン
第12章:原材料、製造コストのような産業チェーン分析。市場チャネル、流通業者、顧客分析
第13章:市場機会と課題分析
第14章:膿痂疹治療薬に関するQYResearchの結論
第15章:QYResearchが採用した方法論とデータソース


ページTOPに戻る


目次

1 Study Coverage
1.1 Impetigo Medicines Product Introduction
1.2 Market by Type
1.2.1 Global Impetigo Medicines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Traditional Chinese Medicine
1.2.3 Western Medicine
1.3 Market by Application
1.3.1 Global Impetigo Medicines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Impetigo Medicines Sales Estimates and Forecasts 2018-2029
2.2 Global Impetigo Medicines Revenue by Region
2.2.1 Global Impetigo Medicines Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Impetigo Medicines Revenue by Region (2018-2023)
2.2.3 Global Impetigo Medicines Revenue by Region (2024-2029)
2.2.4 Global Impetigo Medicines Revenue Market Share by Region (2018-2029)
2.3 Global Impetigo Medicines Sales Estimates and Forecasts 2018-2029
2.4 Global Impetigo Medicines Sales by Region
2.4.1 Global Impetigo Medicines Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Impetigo Medicines Sales by Region (2018-2023)
2.4.3 Global Impetigo Medicines Sales by Region (2024-2029)
2.4.4 Global Impetigo Medicines Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Impetigo Medicines Sales by Manufacturers
3.1.1 Global Impetigo Medicines Sales by Manufacturers (2018-2023)
3.1.2 Global Impetigo Medicines Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Impetigo Medicines in 2022
3.2 Global Impetigo Medicines Revenue by Manufacturers
3.2.1 Global Impetigo Medicines Revenue by Manufacturers (2018-2023)
3.2.2 Global Impetigo Medicines Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Impetigo Medicines Revenue in 2022
3.3 Global Key Players of Impetigo Medicines, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Impetigo Medicines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Impetigo Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Impetigo Medicines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Impetigo Medicines, Product Offered and Application
3.8 Global Key Manufacturers of Impetigo Medicines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Impetigo Medicines Sales by Type
4.1.1 Global Impetigo Medicines Historical Sales by Type (2018-2023)
4.1.2 Global Impetigo Medicines Forecasted Sales by Type (2024-2029)
4.1.3 Global Impetigo Medicines Sales Market Share by Type (2018-2029)
4.2 Global Impetigo Medicines Revenue by Type
4.2.1 Global Impetigo Medicines Historical Revenue by Type (2018-2023)
4.2.2 Global Impetigo Medicines Forecasted Revenue by Type (2024-2029)
4.2.3 Global Impetigo Medicines Revenue Market Share by Type (2018-2029)
4.3 Global Impetigo Medicines Price by Type
4.3.1 Global Impetigo Medicines Price by Type (2018-2023)
4.3.2 Global Impetigo Medicines Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Impetigo Medicines Sales by Application
5.1.1 Global Impetigo Medicines Historical Sales by Application (2018-2023)
5.1.2 Global Impetigo Medicines Forecasted Sales by Application (2024-2029)
5.1.3 Global Impetigo Medicines Sales Market Share by Application (2018-2029)
5.2 Global Impetigo Medicines Revenue by Application
5.2.1 Global Impetigo Medicines Historical Revenue by Application (2018-2023)
5.2.2 Global Impetigo Medicines Forecasted Revenue by Application (2024-2029)
5.2.3 Global Impetigo Medicines Revenue Market Share by Application (2018-2029)
5.3 Global Impetigo Medicines Price by Application
5.3.1 Global Impetigo Medicines Price by Application (2018-2023)
5.3.2 Global Impetigo Medicines Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Impetigo Medicines Market Size by Type
6.1.1 US & Canada Impetigo Medicines Sales by Type (2018-2029)
6.1.2 US & Canada Impetigo Medicines Revenue by Type (2018-2029)
6.2 US & Canada Impetigo Medicines Market Size by Application
6.2.1 US & Canada Impetigo Medicines Sales by Application (2018-2029)
6.2.2 US & Canada Impetigo Medicines Revenue by Application (2018-2029)
6.3 US & Canada Impetigo Medicines Market Size by Country
6.3.1 US & Canada Impetigo Medicines Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Impetigo Medicines Sales by Country (2018-2029)
6.3.3 US & Canada Impetigo Medicines Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Impetigo Medicines Market Size by Type
7.1.1 Europe Impetigo Medicines Sales by Type (2018-2029)
7.1.2 Europe Impetigo Medicines Revenue by Type (2018-2029)
7.2 Europe Impetigo Medicines Market Size by Application
7.2.1 Europe Impetigo Medicines Sales by Application (2018-2029)
7.2.2 Europe Impetigo Medicines Revenue by Application (2018-2029)
7.3 Europe Impetigo Medicines Market Size by Country
7.3.1 Europe Impetigo Medicines Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Impetigo Medicines Sales by Country (2018-2029)
7.3.3 Europe Impetigo Medicines Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Impetigo Medicines Market Size
8.1.1 China Impetigo Medicines Sales (2018-2029)
8.1.2 China Impetigo Medicines Revenue (2018-2029)
8.2 China Impetigo Medicines Market Size by Application
8.2.1 China Impetigo Medicines Sales by Application (2018-2029)
8.2.2 China Impetigo Medicines Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Impetigo Medicines Market Size by Type
9.1.1 Asia Impetigo Medicines Sales by Type (2018-2029)
9.1.2 Asia Impetigo Medicines Revenue by Type (2018-2029)
9.2 Asia Impetigo Medicines Market Size by Application
9.2.1 Asia Impetigo Medicines Sales by Application (2018-2029)
9.2.2 Asia Impetigo Medicines Revenue by Application (2018-2029)
9.3 Asia Impetigo Medicines Sales by Region
9.3.1 Asia Impetigo Medicines Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Impetigo Medicines Revenue by Region (2018-2029)
9.3.3 Asia Impetigo Medicines Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Impetigo Medicines Market Size by Type
10.1.1 Middle East, Africa and Latin America Impetigo Medicines Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Impetigo Medicines Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Impetigo Medicines Market Size by Application
10.2.1 Middle East, Africa and Latin America Impetigo Medicines Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Impetigo Medicines Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Impetigo Medicines Sales by Country
10.3.1 Middle East, Africa and Latin America Impetigo Medicines Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Impetigo Medicines Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Impetigo Medicines Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Cutanea Life Sciences
11.1.1 Cutanea Life Sciences Company Information
11.1.2 Cutanea Life Sciences Overview
11.1.3 Cutanea Life Sciences Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Cutanea Life Sciences Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Cutanea Life Sciences Recent Developments
11.2 LEO Pharma
11.2.1 LEO Pharma Company Information
11.2.2 LEO Pharma Overview
11.2.3 LEO Pharma Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 LEO Pharma Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 LEO Pharma Recent Developments
11.3 Medimetriks Pharmaceuticals
11.3.1 Medimetriks Pharmaceuticals Company Information
11.3.2 Medimetriks Pharmaceuticals Overview
11.3.3 Medimetriks Pharmaceuticals Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Medimetriks Pharmaceuticals Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Medimetriks Pharmaceuticals Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Overview
11.4.3 GlaxoSmithKline Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 GlaxoSmithKline Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GlaxoSmithKline Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Pfizer Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Karalex Pharma, LLC
11.6.1 Karalex Pharma, LLC Company Information
11.6.2 Karalex Pharma, LLC Overview
11.6.3 Karalex Pharma, LLC Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Karalex Pharma, LLC Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Karalex Pharma, LLC Recent Developments
11.7 NovaBay Pharmaceuticals, Inc.
11.7.1 NovaBay Pharmaceuticals, Inc. Company Information
11.7.2 NovaBay Pharmaceuticals, Inc. Overview
11.7.3 NovaBay Pharmaceuticals, Inc. Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 NovaBay Pharmaceuticals, Inc. Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 NovaBay Pharmaceuticals, Inc. Recent Developments
11.8 Roche Holding AG
11.8.1 Roche Holding AG Company Information
11.8.2 Roche Holding AG Overview
11.8.3 Roche Holding AG Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Roche Holding AG Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Roche Holding AG Recent Developments
11.9 SANDOZ GmbH
11.9.1 SANDOZ GmbH Company Information
11.9.2 SANDOZ GmbH Overview
11.9.3 SANDOZ GmbH Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 SANDOZ GmbH Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 SANDOZ GmbH Recent Developments
11.10 Taro Pharmaceutical Industries Ltd
11.10.1 Taro Pharmaceutical Industries Ltd Company Information
11.10.2 Taro Pharmaceutical Industries Ltd Overview
11.10.3 Taro Pharmaceutical Industries Ltd Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Taro Pharmaceutical Industries Ltd Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Taro Pharmaceutical Industries Ltd Recent Developments
11.11 Teva Pharmaceutical Industries Ltd
11.11.1 Teva Pharmaceutical Industries Ltd Company Information
11.11.2 Teva Pharmaceutical Industries Ltd Overview
11.11.3 Teva Pharmaceutical Industries Ltd Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Teva Pharmaceutical Industries Ltd Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Teva Pharmaceutical Industries Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Impetigo Medicines Industry Chain Analysis
12.2 Impetigo Medicines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Impetigo Medicines Production Mode & Process
12.4 Impetigo Medicines Sales and Marketing
12.4.1 Impetigo Medicines Sales Channels
12.4.2 Impetigo Medicines Distributors
12.5 Impetigo Medicines Customers
13 Market Dynamics
13.1 Impetigo Medicines Industry Trends
13.2 Impetigo Medicines Market Drivers
13.3 Impetigo Medicines Market Challenges
13.4 Impetigo Medicines Market Restraints
14 Key Findings in The Global Impetigo Medicines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

Global Impetigo Medicines market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Impetigo Medicines industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2023 to 2029.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:
This report presents an overview of global Impetigo Medicines market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Impetigo Medicines market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Cutanea Life Sciences
LEO Pharma
Medimetriks Pharmaceuticals
GlaxoSmithKline
Pfizer
Karalex Pharma, LLC
NovaBay Pharmaceuticals, Inc.
Roche Holding AG
SANDOZ GmbH
Taro Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd
Segment by Type
Traditional Chinese Medicine
Western Medicine
Segment by Application
Hospital
Pharmacy
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline
Chapter 1: Product definition, type and application introduction
Chapter 2: Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3: Manufacturers’ sales, revenue and price analysis, including manufacturers’ Impetigo Medicines plant distribution, commercial date of Impetigo Medicines, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4: Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5: Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6: Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7: Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8: Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9: Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10: Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11: Manufacturers’ outline, covering company’s basic information, major business, Impetigo Medicines introduction, etc. Impetigo Medicines Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12: Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13: Market opportunities and challenges analysis
Chapter 14: QYResearch’s Conclusions of Impetigo Medicines
Chapter 15: Methodology and Data Sources adopted by QYResearch



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Impetigo Medicines Product Introduction
1.2 Market by Type
1.2.1 Global Impetigo Medicines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Traditional Chinese Medicine
1.2.3 Western Medicine
1.3 Market by Application
1.3.1 Global Impetigo Medicines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Impetigo Medicines Sales Estimates and Forecasts 2018-2029
2.2 Global Impetigo Medicines Revenue by Region
2.2.1 Global Impetigo Medicines Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Impetigo Medicines Revenue by Region (2018-2023)
2.2.3 Global Impetigo Medicines Revenue by Region (2024-2029)
2.2.4 Global Impetigo Medicines Revenue Market Share by Region (2018-2029)
2.3 Global Impetigo Medicines Sales Estimates and Forecasts 2018-2029
2.4 Global Impetigo Medicines Sales by Region
2.4.1 Global Impetigo Medicines Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Impetigo Medicines Sales by Region (2018-2023)
2.4.3 Global Impetigo Medicines Sales by Region (2024-2029)
2.4.4 Global Impetigo Medicines Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Impetigo Medicines Sales by Manufacturers
3.1.1 Global Impetigo Medicines Sales by Manufacturers (2018-2023)
3.1.2 Global Impetigo Medicines Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Impetigo Medicines in 2022
3.2 Global Impetigo Medicines Revenue by Manufacturers
3.2.1 Global Impetigo Medicines Revenue by Manufacturers (2018-2023)
3.2.2 Global Impetigo Medicines Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Impetigo Medicines Revenue in 2022
3.3 Global Key Players of Impetigo Medicines, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Impetigo Medicines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Impetigo Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Impetigo Medicines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Impetigo Medicines, Product Offered and Application
3.8 Global Key Manufacturers of Impetigo Medicines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Impetigo Medicines Sales by Type
4.1.1 Global Impetigo Medicines Historical Sales by Type (2018-2023)
4.1.2 Global Impetigo Medicines Forecasted Sales by Type (2024-2029)
4.1.3 Global Impetigo Medicines Sales Market Share by Type (2018-2029)
4.2 Global Impetigo Medicines Revenue by Type
4.2.1 Global Impetigo Medicines Historical Revenue by Type (2018-2023)
4.2.2 Global Impetigo Medicines Forecasted Revenue by Type (2024-2029)
4.2.3 Global Impetigo Medicines Revenue Market Share by Type (2018-2029)
4.3 Global Impetigo Medicines Price by Type
4.3.1 Global Impetigo Medicines Price by Type (2018-2023)
4.3.2 Global Impetigo Medicines Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Impetigo Medicines Sales by Application
5.1.1 Global Impetigo Medicines Historical Sales by Application (2018-2023)
5.1.2 Global Impetigo Medicines Forecasted Sales by Application (2024-2029)
5.1.3 Global Impetigo Medicines Sales Market Share by Application (2018-2029)
5.2 Global Impetigo Medicines Revenue by Application
5.2.1 Global Impetigo Medicines Historical Revenue by Application (2018-2023)
5.2.2 Global Impetigo Medicines Forecasted Revenue by Application (2024-2029)
5.2.3 Global Impetigo Medicines Revenue Market Share by Application (2018-2029)
5.3 Global Impetigo Medicines Price by Application
5.3.1 Global Impetigo Medicines Price by Application (2018-2023)
5.3.2 Global Impetigo Medicines Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Impetigo Medicines Market Size by Type
6.1.1 US & Canada Impetigo Medicines Sales by Type (2018-2029)
6.1.2 US & Canada Impetigo Medicines Revenue by Type (2018-2029)
6.2 US & Canada Impetigo Medicines Market Size by Application
6.2.1 US & Canada Impetigo Medicines Sales by Application (2018-2029)
6.2.2 US & Canada Impetigo Medicines Revenue by Application (2018-2029)
6.3 US & Canada Impetigo Medicines Market Size by Country
6.3.1 US & Canada Impetigo Medicines Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Impetigo Medicines Sales by Country (2018-2029)
6.3.3 US & Canada Impetigo Medicines Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Impetigo Medicines Market Size by Type
7.1.1 Europe Impetigo Medicines Sales by Type (2018-2029)
7.1.2 Europe Impetigo Medicines Revenue by Type (2018-2029)
7.2 Europe Impetigo Medicines Market Size by Application
7.2.1 Europe Impetigo Medicines Sales by Application (2018-2029)
7.2.2 Europe Impetigo Medicines Revenue by Application (2018-2029)
7.3 Europe Impetigo Medicines Market Size by Country
7.3.1 Europe Impetigo Medicines Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Impetigo Medicines Sales by Country (2018-2029)
7.3.3 Europe Impetigo Medicines Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Impetigo Medicines Market Size
8.1.1 China Impetigo Medicines Sales (2018-2029)
8.1.2 China Impetigo Medicines Revenue (2018-2029)
8.2 China Impetigo Medicines Market Size by Application
8.2.1 China Impetigo Medicines Sales by Application (2018-2029)
8.2.2 China Impetigo Medicines Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Impetigo Medicines Market Size by Type
9.1.1 Asia Impetigo Medicines Sales by Type (2018-2029)
9.1.2 Asia Impetigo Medicines Revenue by Type (2018-2029)
9.2 Asia Impetigo Medicines Market Size by Application
9.2.1 Asia Impetigo Medicines Sales by Application (2018-2029)
9.2.2 Asia Impetigo Medicines Revenue by Application (2018-2029)
9.3 Asia Impetigo Medicines Sales by Region
9.3.1 Asia Impetigo Medicines Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Impetigo Medicines Revenue by Region (2018-2029)
9.3.3 Asia Impetigo Medicines Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Impetigo Medicines Market Size by Type
10.1.1 Middle East, Africa and Latin America Impetigo Medicines Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Impetigo Medicines Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Impetigo Medicines Market Size by Application
10.2.1 Middle East, Africa and Latin America Impetigo Medicines Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Impetigo Medicines Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Impetigo Medicines Sales by Country
10.3.1 Middle East, Africa and Latin America Impetigo Medicines Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Impetigo Medicines Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Impetigo Medicines Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Cutanea Life Sciences
11.1.1 Cutanea Life Sciences Company Information
11.1.2 Cutanea Life Sciences Overview
11.1.3 Cutanea Life Sciences Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Cutanea Life Sciences Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Cutanea Life Sciences Recent Developments
11.2 LEO Pharma
11.2.1 LEO Pharma Company Information
11.2.2 LEO Pharma Overview
11.2.3 LEO Pharma Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 LEO Pharma Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 LEO Pharma Recent Developments
11.3 Medimetriks Pharmaceuticals
11.3.1 Medimetriks Pharmaceuticals Company Information
11.3.2 Medimetriks Pharmaceuticals Overview
11.3.3 Medimetriks Pharmaceuticals Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Medimetriks Pharmaceuticals Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Medimetriks Pharmaceuticals Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Overview
11.4.3 GlaxoSmithKline Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 GlaxoSmithKline Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GlaxoSmithKline Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Pfizer Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Karalex Pharma, LLC
11.6.1 Karalex Pharma, LLC Company Information
11.6.2 Karalex Pharma, LLC Overview
11.6.3 Karalex Pharma, LLC Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Karalex Pharma, LLC Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Karalex Pharma, LLC Recent Developments
11.7 NovaBay Pharmaceuticals, Inc.
11.7.1 NovaBay Pharmaceuticals, Inc. Company Information
11.7.2 NovaBay Pharmaceuticals, Inc. Overview
11.7.3 NovaBay Pharmaceuticals, Inc. Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 NovaBay Pharmaceuticals, Inc. Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 NovaBay Pharmaceuticals, Inc. Recent Developments
11.8 Roche Holding AG
11.8.1 Roche Holding AG Company Information
11.8.2 Roche Holding AG Overview
11.8.3 Roche Holding AG Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Roche Holding AG Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Roche Holding AG Recent Developments
11.9 SANDOZ GmbH
11.9.1 SANDOZ GmbH Company Information
11.9.2 SANDOZ GmbH Overview
11.9.3 SANDOZ GmbH Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 SANDOZ GmbH Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 SANDOZ GmbH Recent Developments
11.10 Taro Pharmaceutical Industries Ltd
11.10.1 Taro Pharmaceutical Industries Ltd Company Information
11.10.2 Taro Pharmaceutical Industries Ltd Overview
11.10.3 Taro Pharmaceutical Industries Ltd Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Taro Pharmaceutical Industries Ltd Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Taro Pharmaceutical Industries Ltd Recent Developments
11.11 Teva Pharmaceutical Industries Ltd
11.11.1 Teva Pharmaceutical Industries Ltd Company Information
11.11.2 Teva Pharmaceutical Industries Ltd Overview
11.11.3 Teva Pharmaceutical Industries Ltd Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Teva Pharmaceutical Industries Ltd Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Teva Pharmaceutical Industries Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Impetigo Medicines Industry Chain Analysis
12.2 Impetigo Medicines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Impetigo Medicines Production Mode & Process
12.4 Impetigo Medicines Sales and Marketing
12.4.1 Impetigo Medicines Sales Channels
12.4.2 Impetigo Medicines Distributors
12.5 Impetigo Medicines Customers
13 Market Dynamics
13.1 Impetigo Medicines Industry Trends
13.2 Impetigo Medicines Market Drivers
13.3 Impetigo Medicines Market Challenges
13.4 Impetigo Medicines Market Restraints
14 Key Findings in The Global Impetigo Medicines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/10/04 10:27

147.72 円

163.39 円

196.69 円

ページTOPに戻る